Combination Therapy Could Be Effective Against Ovarian Cancer (calpeptin) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, November 05, 2016

Combination Therapy Could Be Effective Against Ovarian Cancer (calpeptin)



medical news
November 3, 2016 

Researchers at Boston University School of Medicine have identified a combination therapy which may be effective against certain types of ovarian cancer. The research was published in the journal, Anticancer Research.
According to the study authors, the triple drug combination therapy could be an effective treatment option for patients whose cancer has developed resistance to chemotherapy and other conventional treatments. The therapy combines a calpain inhibitor, known as calpeptin, with two different histone deacetylase inhibitors, sodium butyrate and suberanilohydroxamic acid (SAHA).....
 
 Other studies have supported this idea by showing that epigenetic drugs make drug resistant cancer cells more susceptible to platinum therapies.
 

0 comments :

Post a Comment

Your comments?